Quantum Genomics Corp. Announces Successful Phase Ia Data With QGC001, Its Lead Compound for the Treatment of Hypertension
10/19/2012 10:05:20 AM
More...
|
Quantum Genomics Corp. Announces Initiation of a First-in-Human Clinical Study With QGC001, Its Lead Compound for the Treatment of Hypertension
4/13/2012 9:31:58 AM
More...
|
Quantum Genomics Corp. Gets Approval from the Patients' Protection Committee
1/5/2012 9:03:40 AM
More...
|
Quantum Genomics Corp. (Nyse Euronext Paris: MLQGC) Announced Today Positive Scientific Results With Its Product QGC001
4/1/2011 8:22:40 AM
More...
|
Quantum Genomics Corp. (NYSE Euronext Paris: MLQGC) Announced Today that EUR 1.4 Million in Funding has Been Granted by the National Research Agency (ANR) for a Collaborative Research Project Named BAPAI
2/2/2011 8:16:31 AM
More...
|
Quantum Genomics Corp. Enters the NYSE-Euronext Market (MLQGC)
7/28/2009 9:18:44 AM
More...
|
Quantum Genomics Corp. Gets 1 Million $ (740 K€) From Oseo to Finance the Regulatory Preclinical Development of QGC 001
4/2/2009 9:45:40 AM
More...
|
Quantum Genomics Corp. Signs Strategic Agreement With PCAS To Make First Batch of Hypertension Drug Candidate
7/8/2008 8:48:49 AM
More...
|
Quantum Genomics Corp. Partners with INSERM in Stroke and Cardiac Ischemia Drug Development
1/24/2008 8:51:08 AM
More...
|
Quantum Genomics Corp. Widens Net with Acquisition of Eurobiobiz SAS
10/29/2007 2:30:13 PM
More...
|
|